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Summary
NMDA receptors (NMDARs) control bidirectional syn-
aptic plasticity by regulating postsynaptic AMPA
receptors (AMPARs). Here we show that NMDAR acti-
vation can have differential effects on AMPAR traffick-
ing, depending on the subunit composition of NMDARs.
In mature cultured neurons, NR2A-NMDARs promote,
whereas NR2B-NMDARs inhibit, the surface expres-
sion of GluR1, primarily by regulating its surface in-
sertion. In mature neurons, NR2B is coupled to inhibi-
tion rather than activation of the Ras-ERK pathway,
which drives surface delivery of GluR1. Moreover, the
synaptic Ras GTPase activating protein (GAP) Syn-
GAP is selectively associated with NR2B-NMDARs in
brain and is required for inhibition of NMDAR-depen-
dent ERK activation. Preferential coupling of NR2B to
SynGAP could explain the subtype-specific function
of NR2B-NMDARs in inhibition of Ras-ERK, removal
of synaptic AMPARs, and weakening of synaptic
transmission.
Introduction
NMDAR-mediated Ca2+ influx into the postsynaptic cell
triggers signal transduction cascades that control ac-
tivity-dependent modification of synapses and neu-
ronal survival (Sheng and Kim, 2002). NMDARs are be-
lieved to be tetrameric complexes assembled from two
NR1 and two NR2 subunits. The different NR2 subunits
(NR2A-NR2D) confer distinct gating and pharmacologi-
cal properties on the heteromeric receptor channel. For
instance, NMDARs of NR1/NR2A composition have
faster kinetics of deactivation than NR1/NR2B recep-
tors (Cull-Candy et al., 2001). In adult hippocampus and
neocortex, NR2A and NR2B are the predominant NR2
subunits. The subtypes of NMDARs present are there-
fore believed to be a mixture of NR1/NR2A (which we
will term NR2A-NMDARs), NR1/NR2B (NR2B-NMDARs),
and NR1/NR2A/NR2B (Sheng et al., 1994). The expres-*Correspondence: msheng@mit.edu
3 Present address: Department of Neurology, MassGeneral Institute
for Neurodegenerative Disease, Harvard Medical School and Mas-
sachusetts General Hospital, Charlestown, Massachusetts 02129.sion of NR2B is already high at birth, remains sustained
through postnatal development, and declines during
adulthood. On the other hand, NR2A expression ap-
pears around postnatal day 7 (P7) and increases during
the next 2–3 weeks to adult levels (Monyer et al., 1994;
Sheng et al., 1994). Thus during brain maturation,
NR2A-containing NMDARs are added to, and perhaps
partly replace, NR2B-containing receptors in synapses
(Flint et al., 1997; Stocca and Vicini, 1998). In mature
neurons, most NR2A-containing NMDARs are incorpo-
rated in synapses; NR2B-containing NMDARs are also
present in synapses, but they are the predominant sub-
type at extrasynaptic sites (Stocca and Vicini, 1998; To-
var and Westbrook, 1999; Liu et al., 2004).
Activation of NMDARs is required for both long-term
potentiation (LTP) and long-term depression (LTD).
These forms of activity-dependent synaptic plasticity,
the proposed cellular substrates of learning and mem-
ory, are best studied at hippocampal CA1 synapses.
Recently, it was shown that inhibition of NR2B-contain-
ing receptors blocks the induction of LTD but not LTP in
CA1 synapses, whereas specific antagonists of NR2A-
NMDARs prevent the induction of LTP without affecting
LTD (Liu et al., 2004). Similar findings were reported in
perirhinal cortex (Massey et al., 2004). These studies
demonstrated that the polarity of synaptic modification
can be determined by the subunit composition of
NMDARs. However, it is unknown how activation
of NR2A- and NR2B-containing receptors is coupled to
LTP and LTD, respectively. Moreover, the concept of
opposing functions of NR2A- versus NR2B-containing
NMDARs is based primarily on pharmacological experi-
ments in electrophysiological preparations (Liu et al.,
2004; Massey et al., 2004), and it is important to extend
the analysis to a molecular level.
The ERK1/2 (extracellular signal-regulated kinase 1/2)
signaling pathway is activated by calcium influx through
NMDARs and plays an important role in synaptic plas-
ticity and cell survival (Sweatt, 2004; Thomas and Hu-
ganir, 2004). NMDAR-dependent ERK activation in-
volves the small GTPase Ras, which is stimulated by
specific guanine nucleotide exchange factors (GEFs)
and inhibited by GTPase activating proteins (GAPs)
(Thomas and Huganir, 2004). The RasGEF RasGRF1 is
reported to bind directly to the NR2B subunit of
NMDARs (Krapivinsky et al., 2003). SynGAP, a RasGAP
highly enriched in the postsynaptic density (PSD), can
associate with NMDARs through binding to PSD-95
family proteins (Chen et al., 1998; Kim et al., 1998). The
exact function of these Ras regulatory proteins in syn-
aptic plasticity has not been established, and how they
are functionally coupled to NMDARs remains unclear.
Altered AMPAR trafficking has emerged as a major
postsynaptic mechanism for the expression of synaptic
plasticity (Malinow and Malenka, 2002). A prevailing
model is that NMDAR-dependent LTP is mediated by
the surface insertion and synaptic delivery of GluR1,
which is driven by CaM kinase II and the Ras-ERK path-
way (Hayashi et al., 2000; Shi et al., 2001; Passafaro et
al., 2001; Zhu et al., 2002). On the other hand, LTD is
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Bsynaptic AMPARs by the increased endocytosis and/or
reduced recycling of GluR2/3 subunits (Beattie et al., b
w2000; Lee et al., 2002; Lee et al., 2004; Zhu et al., 2002).
In this study, we investigate the links between N
oNMDAR subtypes, Ras-ERK signaling, and AMPAR
trafficking. We find that NR2A and NR2B have antago- P
snistic actions on Ras-ERK activation and AMPAR distri-
bution in mature neurons. NR2A-NMDARs promote, s
Gwhereas NR2B-NMDARs inhibit, the surface expression
of GluR1—primarily by regulating GluR1 surface inser- d
ation. Potentially accounting for this difference is that
NR2B is coupled to the inhibition rather than the activa- t
mtion of the Ras-ERK pathway. This functional coupling
is correlated with the specific biochemical association f
sof SynGAP with NR2B-NMDARs.
nResults
n
tNR2B Antagonists Increase Surface GluR1
oBecause NR2B-selective NMDAR antagonists prevent
LTD but not LTP (Liu et al., 2004), we hypothesized that
the NR2B subunit is coupled preferentially to the loss N
of surface AMPARs. To test this idea, we treated mature T
(DIV30) cultured hippocampal neurons with the drugs t
ifenprodil (NR2B-selective antagonist; 5 M) or DL-APV (
(a “pan” NMDAR blocker; 100 M) for 30 min. Ifenprodil s
increased surface GluR1 by w40%, as quantified by (
surface immunofluorescence intensity using an anti- s
body directed against the extracellular N-terminal re- b
gion of GluR1 (Figure 1A). By contrast, APV caused a t
significant reduction (w20%) in surface GluR1 expres- N
sion. Neither drug affected surface levels of GluR2 (Fig- f
ure 1A). Total GluR1 and GluR2/3 protein levels were N
also unchanged by ifenprodil or APV treatment for 30
min (data not shown). The opposite effects of ifenprodil R
and APV on surface GluR1 cannot be explained by a
quantitative differences in inhibition of total NMDAR ac- N
tivity. Instead, our finding implies that “tonic” activity d
of ifenprodil-sensitive NMDARs in mature hippocampal e
cultures promotes the removal of surface GluR1. d
Surface biotinylation assays confirmed that steady- n
state surface GluR1 levels were increased by ifenprodil s
(5 M, 30 min), with no significant effect on surface f
GluR2/3 (Figure 1B). NMDA stimulation of cultured neu- v
rons is well known to induce internalization of AMPARs, 9
which can be quantified by surface biotinylation assays p
(Lin et al., 2000; Ehlers, 2000). In high-density cortical e
neurons (DIV21), NMDA (70 M, 20 min) stimulated the F
loss of endogenous GluR1 and GluR2/3 from the cell s
surface (Figure 1B). This internalization was abolished n
by pretreatment with ifenprodil (5 M) (Figure 1B). Thus, m
ifenprodil-sensitive NR2B-NMDARs are required for t
NMDA-induced removal of surface AMPARs. d
e
kOverexpression of NR2B Inhibits Surface
Expression of GluR1 a
iTo obtain molecular genetic corroboration of our phar-
macological findings, we overexpressed the NR2B sub- t
eunit in DIV14 cultured hippocampal neurons, and 3
days later we quantified the steady-state level of sur-
dface GluR1 and GluR2 (Figure 2). NR2B overexpression
reduced surface GluR1 by w45% (Figures 2A and 2C), Uithout affecting surface GluR2 (Figures 2B and 2C).
oth synaptic and extrasynaptic GluR1 were reduced
y NR2B overexpression, as judged by colocalization
ith PSD-95 (Figures 2A and 2C). Overexpression of
R2A had no significant effect on surface expression
f either GluR1 or GluR2 (Figure 2). Punctate dendritic
SD-95 localization was not affected by overexpres-
ion of NR2A or NR2B (Figure 2). Nor did overexpres-
ion of NR2B or NR2A affect total levels of GluR1 or
luR2 in transfected neurons (either in soma or den-
rites) (Figures S1A and S1B in the Supplemental Data
vailable with this article online). Therefore, the reduc-
ion of surface GluR1 induced by NR2B overexpression
ost likely reflects a redistribution of GluR1 from sur-
ace to intracellular pools, rather than reduced tran-
cription and/or translation of GluR1.
By contrast, overexpression of NR2B in immature
eurons (transfected at DIV6 and stained at DIV9) had
o effect on surface GluR1 (Figure S1C), suggesting
hat the reduction of surface GluR1 induced by NR2B
verexpression is developmentally regulated.
R2A Promotes Surface Expression of GluR1
o complement the overexpression experiments, we
urned to plasmid-based RNA interference (RNAi)
Brummelkamp et al., 2002) to knock down the expres-
ion of NR2A or NR2B in cultured hippocampal neurons
Figure 3). In COS-7 cells, the NR2A-RNAi plasmid
trongly reduced expression of cotransfected NR2A,
ut not of cotransfected NR2B (Figure 3A). Conversely,
he NR2B-RNAi construct suppressed NR2B, but not
R2A expression. Thus, both RNAi constructs are ef-
ective and specific against heterologously expressed
R2 subunits.
Neurons were cotransfected at DIV14 with NR2A-
NAi plasmid and β-gal expression plasmid (to mark
nd fill the transfected neuron) and analyzed at DIV17.
R2A-RNAi virtually eliminated immunostaining for en-
ogenous NR2A; however, endogenous NR2B and NR1
xpression were quantitatively unchanged in soma and
endrites (Figures 3B and 3C). Knockdown of endoge-
ous NR2A resulted in w40% reduction in the steady-
tate level of surface GluR1, but had little effect on sur-
ace GluR2 (Figure 4A and 4B). The empty pSUPER
ector, or a pSUPER-RNAi construct targeting the PSD-
5 family member SAP102, did not alter the surface ex-
ression of GluR1 or GluR2 (Figures 4A and 4B). (The
fficacy and specificity of SAP102-RNAi is shown in
igure S2A). Despite inhibiting surface GluR1 expres-
ion, NR2A-RNAi led to an increase in total GluR1 (but
ot GluR2) levels in both cell soma and dendrites, as
easured by immunostaining in permeabilized condi-
ions (Figures S3A–S3C). Taken together, these data in-
icate that the NR2A subunit is important for surface
xpression of GluR1, but not GluR2. The same RNAi
nockdown of NR2A did not prevent NMDA-induced
ctivation of ERK (see Figures 7C and 7E) or NMDA-
nduced GluR2 internalization (see Figure 6), implying
hat some functional NMDARs remained despite loss of
ndogenous NR2A.
The NR2B-RNAi construct was also successful in re-
ucing NR2B immunostaining in transfected neurons.
nexpectedly, however, NR2B-RNAi also strongly de-
Differential Functions of NR2A versus NR2B
747Figure 1. NR2B Antagonists Increase Surface Expression and Prevent NMDA-Induced Internalization of AMPARs
(A) Cultured hippocampal neurons at DIV30 were treated with DMSO (control), 5 M ifenprodil, or 100 M DL-APV for 30 min, and surface
GluR1 and GluR2 were measured by immunostaining. The histogram shows the mean ± SEM of surface GluR intensity. n = 17, 12, 13, 19, 13,
and 15 neurons for each condition from left to right. ***p < 0.001 relative to surface GluR1 intensity in DMSO-treated control. There were no
significant differences in surface GluR2 intensity.
(B) Ifenprodil blocks NMDA-induced reduction in surface AMPA receptors. Cortical neurons at DIV21 were pretreated with DMSO or 5 M
ifenprodil for 10 min, and subsequently cells were either untreated or treated with 70 M NMDA. After 20 min, cell surface proteins were
biotinylated, and biotinylated proteins were purified and immunoblotted for GluR1, GluR2/3, and N-cadherin. For protein normalization, cell
lysates were analyzed with GRIP antibody. n = 3, **p < 0.01, *p < 0.05, compared with DMSO control.creased NR2A staining in the same cells (by w75% in
soma and dendrites; Figures 3B and 3C). Total NR1
immunostaining in dendrites was strongly reduced in
neurons transfected with the NR2B-RNAi construct;
however, the intensity of NR1 staining in the cell body
was unchanged (Figures 3B and 3C and Figure S4B).
The specific loss of NR1 from dendrites of NR2B-RNAi
neurons suggests that NR2 subunits are important for
the dendritic targeting of NR1. Two additional NR2B-
RNAi constructs targeting different sequences in NR2B
gave similar effects on NR2A and NR1 expression (data
not shown). We note that NR2B-RNAi had no effect on
PSD-95 levels in dendrites (Figure S4A) or on total
GluR1 levels (Figures S5A and S5C), suggesting that
the NR2B-RNAi construct does not nonspecifically in-
hibit gene expression in neurons. NR2B-RNAi caused
apparent spine loss, as judged by staining of cotrans-
fected β-gal (Figure S4A). Protrusion density (number
of protrusions of greater than 1 m length per 10 mof dendrite) was reduced by w70% in NR2B-RNAi neu-
rons (4.194 ± 0.2734 in pSUPER control and 1.228 ±
0.1036 in NR2B-RNAi transfected neurons, p < 0.001).
Because the NR2B-RNAi does not “cross-react”
against NR2A in COS-7 cells (Figure 3A), these results
suggest that NR2B might be required in neurons for ex-
pression and/or stability of endogenous NR2A. What-
ever the reason, the effects of NR2B-RNAi make it diffi-
cult to interpret with regard to function of NR2A versus
NR2B. To circumvent this problem, we cotransfected
an NR2A-expression plasmid together with the NR2B-
RNAi plasmid, thereby generating neurons that should
have predominantly NR2A-NMDARs.
Neurons transfected with the NR2B-RNAi construct
showed almost complete loss of surface GluR1 staining
(w5% of control) (Figure 4C), despite little change in
total GluR1 levels in soma and dendrites of these cells
(see Figures S5A and S5C). NR2B-RNAi also caused
w50% reduction in surface GluR2 level (data not
Neuron
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Surface Expression of GluR1 in Mature
Neurons
(A and B) Hippocampal neurons were trans-
fected at DIV14 with NR2A or NR2B, and en-
dogenous surface GluR1 (A) and surface
GluR2 levels (B) were measured at DIV17 by
immunofluorescence staining. Neurons were
triple labeled for surface GluR (GluR1 or
GluR2), NR2 subunit (NR2A or NR2B), and
PSD-95.
(C) (Left panel) Quantification of surface
GluR1 and GluR2 levels in neurons trans-
fected with NR2A or NR2B, normalized to
untransfected neurons. The histogram shows
the mean ± SEM of surface GluR intensity in
dendrites. n = 25, 18, 19, 19, 17, and 16 neu-
rons from left to right. **p < 0.01, compared
with untransfected neuron or NR2A-trans-
fected neurons. (Right panel) Quantification
of surface GluR1 intensity within PSD-95
puncta in neurons transfected with NR2A or
NR2B, normalized to untransfected neurons.
Approximately 1000 puncta per construct
were analyzed. ***p < 0.001, compared with
untransfected neurons or NR2A-transfected
neurons.shown). Cotransfection of NR2A-expression plasmid w
cwith the NR2B-RNAi construct (cells identified by stain-
ing for cotransfected β-gal and/or NR2A) did not “res- s
tcue” the surface levels of GluR1 (w8% of control) (Fig-
ure 4C). These results suggest that NR2A-NMDARs are r
Fnot sufficient to support surface expression of GluR1
and that perhaps both NR2A and NR2B are required.
Several lines of evidence indicate that exogenous N
DNR2A coexpression reconstituted NR2A-NMDARs in
neurons transfected with NR2B-RNAi. First, cotransfec- W
ttion of NR2A restored the dendritic NR1 staining that is
suppressed by NR2B-RNAi. The rescued dendritic NR1 a
Lstaining colocalized in punctate fashion with the trans-
fected NR2A, implying that NR2A had formed NR2A/ N
tNR1 heteromeric NMDARs with endogenous NR1 (Fig-
ure S4B). Second, exogenously expressed NR2A in a
wNR2B-RNAi neurons formed clusters that colocalizedith PSD-95 (Figure S4A), implying that these NR2A-
ontaining NMDA receptors were targeted properly to
ynapses. Third, NR2A coexpression was able to func-
ionally rescue NMDA-induced ERK activation in neu-
ons transfected with the NR2B-RNAi construct (see
igures 7D and 7E).
R2A Is Required to Promote Surface
elivery of GluR1
hy does knockdown of NR2A cause selective reduc-
ion of GluR1 on the neuronal surface (Figures 4A
nd 4B)? Given that NR2A-selective antagonists block
TP, an attractive hypothesis is that NR2A-containing
MDARs promote surface insertion of GluR1. To test
his possibility, we used the “thrombin surface cleavage
ssay” (Passafaro et al., 2001). AMPAR subunits tagged
ith an N-terminal extracellular HA-epitope followed by
Differential Functions of NR2A versus NR2B
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(A) Specificity and efficacy of NR2A-RNAi and NR2B-RNAi in COS-7 cells. COS cells were transfected with expression vectors for rat NR2A
or rat NR2B, plus pSUPER RNAi vector, NR2A-RNAi, or NR2B-RNAi constructs, as indicated. Extracts were immunoblotted 2 days later for
NR2A, NR2B, and tubulin.
(B) Specificity and efficacy of NR2A-RNAi and NR2B-RNAi constructs in hippocampal neurons. Cultured hippocampal neurons at DIV14 were
cotransfected with NR2A-RNAi or NR2B-RNAi constructs plus β-gal expression vector (4:1 DNA ratio in favor of RNAi plasmid). Three days
after transfection, neurons were fixed with methanol and double-stained for β-gal and NR2A, NR2B, or NR1, as indicated. Open arrows
indicate cell bodies of transfected neurons.
(C) Quantitation of NR1, NR2A, and NR2B staining in soma and dendrites of neurons transfected with NR2A-RNAi or NR2B-RNAi. The
histogram shows mean ± SEM of immunostaining intensity. n = 12 neurons for each. ***p < 0.001, compared with untransfected neurons.a thrombin protease cleavage site (HA/T-GluR1 and HA/
T-GluR2) were transfected into neurons at DIV14 for 3
days. These overexpressed subunits form largely ho-
momeric AMPARs that can be labeled on the surface
of live neurons with extracellular HA antibodies. Treat-
ment of live neurons with thrombin proteolytically re-
leases the HA tag from AMPARs on the cell surface.
After washout of thrombin, the degree of recovery of
surface HA-labeling over time can be used as a mea-
sure of the rate of surface delivery of AMPARs from
intracellular compartments (Passafaro et al., 2001).
The basal rate of delivery of HA/T-GluR1 from intra-
cellular compartments to the neuronal surface is nor-
mally slow, whereas that of HA/T-GluR2 is rapid (Passa-
faro et al., 2001). At 25 min after thrombin washout, the
amount of HA/T-GluR1 newly inserted into the surface
of neurons transfected with NR2A-RNAi was reduced
by w75% compared to pSUPER-transfected neurons
(Figures 5A and 5C). The amount of HA/T-GluR2 newly
incorporated into the plasma membrane was not signi-
ficantly affected by NR2A knockdown (Figures 5B
and 5C).
We next tested whether activity-induced HA/T-GluR1insertion to the cell surface is affected by NR2A knock-
down. To this end, we employed a cell culture model of
LTP in which glycine is used to activate synaptic NMDA
receptors (Lu et al., 2001). Glycine treatment (200 M, 3
min) stimulated exocytosis of HA/T-GluR1 in pSUPER-
transfected, but not in NR2A-RNAi-transfected neurons
(Figures 5D and 5E). Thus, NR2A is important for induc-
ible as well as “basal” surface insertion of GluR1 recep-
tors in cultured hippocampal neurons.
In the absence of thrombin treatment, we noted that
the steady-state level of intracellular HA/T-GluR1 was
higher in NR2A-RNAi-transfected neurons, whereas the
steady-state level of surface HA/T-GluR1 was lower
(Figure S3D). No such difference was noted for HA/
T-GluR2 (Figure S3E). These findings provide further
evidence that NR2A is important for the redistribution
of GluR1 from intracellular compartments to the neu-
ronal surface (see also Figure 4A).
NR2B Is Sufficient for NMDA-Induced
AMPAR Internalization
The ifenprodil data showed that NR2B-NMDARs are re-
quired for NMDA-induced loss of AMPARs from the
Neuron
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(A and B) Cultured hippocampal neurons at DIV14 were cotransfected with pSUPER, NR2A-RNAi, or SAP102-RNAi, plus β-gal (4:1 ratio).
Three days later, surface GluR1 (A) and surface GluR2 (B) were quantified by immunofluorescence staining (see Experimental Procedures).
The histograms show mean ± SEM of surface GluR1 and GluR2 intensity. n = 26, 25, 21, 21, 25, 18, 25, and 20 neurons from left to right. **p < 0.01,
compared with pSUPER or SAP102-RNAi transfected neuron.
(C) NR2A is not sufficient for surface expression of GluR1. Cultured hippocampal neurons were cotransfected with NR2A expression vector
(NR2A-Exp) plus NR2B-RNAi or with β-gal expression vector plus NR2B-RNAi. Three days later, surface GluR1 was measured by immuno-
staining. The histogram shows mean ± SEM of surface GluR1 intensity. ***p <0.001, compared with untransfected neurons. n = 15, 17, and
15 neurons.neuronal surface (see Figure 1B). To address whether I
cNR2B-NMDARs are sufficient to mediate this response,
the NMDA-induced internalization of endogenous GluR2 a
Nwas measured in NR2A-RNAi knockdown neurons (Figure
6). As quantified by the “antibody-feeding” assay, NR2A- G
bRNAi did not affect GluR2 internalization induced by
NMDA (Figure 6). In NR2A-RNAi-transfected neurons,
talthough steady-state surface GluR1 is reduced by 40%,
GluR1 internalization could still be efficiently induced c
tby NMDA (Figure S6). These data indicate that NR2A is
not required and suggest that NR2B-NMDARs are suffi- f
ccient for removal of surface GluR1 and GluR2 in re-
sponse to NMDA stimulation. a
a
tDifferential Regulation of Ras-ERK Signaling
by NR2A and NR2B I
sRas family GTPases and their downstream MAP ki-nases are involved in regulation of AMPAR trafficking.n particular, the Ras-ERK signaling pathway is impli-
ated in synaptic delivery of GluR1 AMPARs and in syn-
ptic potentiation (Zhu et al., 2002). Because NR2A and
R2B have opposing actions on surface expression of
luR1, we investigated downstream Ras-ERK signaling
y NR2A- and NR2B-NMDARs (Figure 7).
Ras activation was assayed by GST-pulldown using
he Ras-GTP binding domain of Raf-1. In control corti-
al neurons (DIV21), NMDA (70 M) treatment induced
ransient Ras activation, which peaked at w2 min and
ell back to baseline by w5 min (Figure 7A). In parallel
ultures treated with ifenprodil (5 M), NMDA induced
sustained Ras activation, which peaked at w5 min
nd lasted for >30 min (Figure 7A). Thus, the deactiva-
ion of Ras depends on the function of NR2B-NMDARs.
n support of this idea, selective stimulation of extra-
ynaptic NMDARs, which are predominantly NR2B con-taining, caused a net decrease in GTP-Ras (Figure 7A;
Differential Functions of NR2A versus NR2B
751Figure 5. NR2A Is Required for Surface Delivery of GluR1
(A and B) Cultured hippocampal neurons at DIV14 were transfected with HA/T-GluR1 or HA/T-GluR2, plus pSUPER or NR2A-RNAi, as indicated
(1:4 ratio). Three days later, live cells were treated with thrombin, allowed to recover for 25 min in conditioned culture media after thrombin
washout, and labeled for newly inserted surface HA/T-GluR1 (A) or HA/T-GluR2 (B) in the thrombin surface cleavage assay.
(C) Quantitation of results from (A) and (B) normalized to pSUPER-transfected cells. n = 11, 12, 10, and 12 from left to right. **p < 0.01,
compared with pSUPER-transfected neurons.
(D) Cultured hippocampal neurons at DIV14 were transfected with HA/T-GluR1 plus pSUPER or HA/T-GluR1 plus NR2A-RNAi, as indicated
(1:4 ratio). Three days later, live cells were treated with thrombin and then were left unstimulated or were stimulated with glycine (200 M, 3
min in extracellular solution), followed by 10 min in extracellular solution. Newly inserted HA/T-GluR1 was detected by anti-HA surface labeling.
(E) Quantitation of results from (D), normalized to unstimulated pSUPER-transfected cells. ***p < 0.001 (n = 15 neurons for each condition).synaptic NMDARs were blocked by pretreatment with
MK-801; see Experimental Procedures).
Next, we measured surface AMPAR levels after stim-
ulation of synaptic or extrasynaptic NMDARs (Figure
S7). Stimulation of synaptic NMDAR by glycine (Lu et
al., 2001) caused an increase in surface GluR1 (w135%,
compared with untreated neurons). Stimulation of ex-
trasynaptic NMDARs (following blockade of synaptic
NMDA receptors by MK801 [Tovar and Westbrook,
2002]) induced loss of surface GluR1 and GluR2/3 toa similar extent as NMDA stimulation of total NMDA
receptors (Figure S7). Thus, synaptic and extrasynaptic
NMDARs have opposite actions on AMPAR distribu-
tion, correlating with the preferential localization of
NR2A and NR2B in synaptic and extrasynaptic loca-
tions, respectively.
Activation of ERK1/2 is a key downstream event of
Ras signaling, which can be assayed by antibodies that
recognize the phosphorylated, active form of ERK (phos-
pho-ERK). NMDA treatment induced transient ERK acti-
Neuron
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Figure 6. NR2B-NMDARs Are Sufficient for NMDA-Induced
AMPAR Internalization
a
(A and B) Cultured hippocampal neurons (DIV14) were cotrans-
tfected with β-gal plus pSUPER or NR2A-RNAi, as indicated. Three
idays later, cells were left untreated or were treated with NMDA (50
NM for 2 min, followed by return to conditioned media for 8 min)
and internalized and surface-remaining GluR2 were measured by v
fluorescence-based antibody feeding assay (see Experimental Pro- t
cedures). Arrows indicate cell bodies of transfected neurons. l
(C) Quantitation of NMDA-induced GluR2 internalization, measured n
as the ratio of internalized/total fluorescence (internalization index),
inormalized to untreated pSUPER-transfected cells. NMDA-induced
tGluR2 internalization is not significantly different in pSUPER or
TNR2A-RNAi transfected neurons (n = 15 neurons for each con-
dition). r
r
mvation in control hippocampal neurons at DIV15—after a
a large induction at 3 min, phospho-ERK levels sub- t
osided close to baseline by w6 min (Figure 7B, DIV15).owever, in the presence of the NR2B antagonists ifen-
rodil (5 M) or Ro25-6981 (1 M), NMDA-induced ERK
ctivation remained high at 6 min. These results point
o a function of NR2B in “deactivation” of ERK. There
as also a slight but significant inhibition of ERK acti-
ation at 3 min by ifenprodil or Ro25-6981 in neurons
t DIV15 (Figure 7B), suggesting a possible role of
R2B also in ERK activation at this age.
In highly mature neurons (DIV30), NMDA treatment
imilarly caused a transient activation of ERK, albeit
ore modest than at DIV15 (Figure 7B, DIV30). As with
IV15 neurons, ifenprodil and Ro25-6981 converted the
ransient ERK response to NMDA into a sustained acti-
ation. In addition, the NR2B antagonists greatly poten-
iated the magnitude of ERK activation (Figure 7B).
Unlike at DIV15 and DIV30, NMDA stimulation of DIV9
eurons induced a sustained, rather than a transient,
RK activation (Figure 7B, DIV9). Moreover, ifenprodil
irtually abolished this response, indicating that NR2B
eceptors are critical for ERK activation at this more
mmature stage (Figure 7B). Our data suggest that there
s a transition of NR2B function in development—from
mmature neurons, in which NR2B receptors mediate
he sustained activation of ERK, to mature neurons, in
hich NR2B receptors mediate the shut-off of ERK ac-
ivation. Based on these data we conclude that a major
ignaling function of NR2B-NMDARs, particularly in
ature neurons (DIV30), is to dampen the magnitude
nd limit the duration of ERK activation. This conclu-
ion is consistent with the involvement of NR2B-
MDARs in the deactivation of Ras-GTP (Figure 7A).
ither NR2A or NR2B Is Sufficient
or NMDA-Induced ERK Activation
ecause blockade of NR2B-NMDARs does not prevent
ut rather leads to “super”-activation of ERK in mature
eurons, it seems natural to suppose that NR2A-
MDARs are the primary mediators of NMDA-induced
RK activation. However, ifenprodil and Ro25-6981 are
ot necessarily effective antagonists against NR1/
R2A/NR2B-NMDARs (Fischer et al., 1997; Cull-Candy
t al., 2001), and these “triheteromeric” receptors may
ontribute to Ras-ERK activation. Therefore, we took a
olecular genetic approach to the question: are NR2A-
MDARs sufficient to support NMDA-dependent ERK
hosphorylation?
Neurons transfected with NR2A-RNAi alone showed
time course of NMDA-induced ERK activation similar
o untransfected neurons (Figures 7C and 7E), suggest-
ng that NR2A is not essential for ERK activation.
R2B-RNAi-transfected neurons showed no ERK acti-
ation at either 3 min or 6 min following NMDA applica-
ion (Figures 7C and 7E), consistent with the marked
oss of NMDA receptors in these neurons. However,
eurons cotransfected with NR2A expression plasmid
n addition to NR2B-RNAi showed strong ERK activa-
ion that was sustained at 6 min (Figures 7D and 7E).
his result shows that NR2A coexpression functionally
econstitutes NMDARs in NR2B-RNAi-transfected neu-
ons and suggests that NR2A-NMDARs are sufficient to
ediate ERK activation. The sustained ERK activation
t 6 min is consistent with the idea that NR2B recep-
ors, which are lacking in these cells, mediate the shut-
ff of Ras-ERK signaling.
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(A) Time course of NMDA-induced Ras activation. High-density cortical neurons at DIV21 were pretreated either with DMSO or 5 M ifenprodil
for 20 min and then stimulated with 70 M NMDA for the indicated times. For activation of extrasynaptic receptors, neurons were treated
with 20 M MK-801 for 30 min in conditioned culture media, and spontaneous synaptic glutamate release in high-density culture was used
to block synaptic NMDA receptors (Tovar and Westbrook, 2002). Ras activation was assayed by GST-pulldown using the Ras-GTP binding
domain of Raf-1. Three independent experiments showed similar results.
(B) Time course of NMDA-induced ERK activation. Hippocampal neurons at DIV9, DIV15, or DIV30 were pretreated with 1 M TTX, 40 M
CNQX, and 5 M nimodipine (for 1 hr) plus either DMSO, ifenprodil, or Ro25-6981 (for 20 min) and then stimulated with NMDA (70 M) for
the indicated times. ERK activation was analyzed by immunoblotting with phospho-ERK antibody. Graphs show quantitation of fold ERK
activation at 3 and 6 min after NMDA stimulation (n = 3). Band intensities of phospho-ERK were normalized to band intensity of total ERK.
(C) Cultured hippocampal neurons were cotransfected at DIV14 for 3 days with NR2A-RNAi plus β-gal or NR2B-RNAi plus β-gal (4:1 ratio).
Neurons were pretreated with 40 M CNQX, 1 M TTX, and 5 M nimodipine for 1 hr before NMDA stimulation (70 M, 3 min and 6 min),
and ERK activation was measured by immunostaining using phospho-ERK antibody. Transfected neurons were identified with staining with
β-gal antibody.
(D) Cultured hippocampal neurons were transfected at DIV14 with NR2A-expression plasmid plus NR2B-RNAi or NR2B-expression plasmid
plus NR2A-RNAi (1:4 ratio). At DIV17, neurons were pretreated with 1 M TTX, 40 M CNQX, and 5 M nimodipine for 1 hr, then stimulated
with 70 M NMDA (3 min or 6 min), and ERK activation was measured by immunostaining with phospho-ERK antibody. Transfected neurons
were identified by staining with NR2B or NR2A antibody. Arrows indicate soma of transfected neurons.
(E) Quantitation of data from (C) and (D). For quantification of phospho-ERK intensity, fluorescence intensity over cell soma was measured.
Data were normalized to ERK activation levels at 3 min in untransfected neurons. Histograms show mean ± SEM. n = 32, 17, 15, 21, 22, 29,
19, 15, 21, and 19 neurons from left to right. ***p < 0.001, **p <0.01, compared with untransfected neurons.In neurons transfected with NR2A-RNAi plus NR2B
expression constructs, ERK activation was normal and
transient, similar to untransfected neurons—i.e., ERK
activation at 6 min was decreased relative to 3 min (Fig-
ures 7D and 7E). The phenotype is similar to that seenwith NR2A-RNAi alone. Taken together, these data ar-
gue that either NR2A or NR2B receptors can support
NMDA-induced ERK activation; however, NR2B-NMDA
receptors are required to dampen the ERK activation at
6 min (i.e., shorten the duration of ERK activation).
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Mwith the conclusions from the pharmacological experi-
ments (Figure 7B). T
N
uSynGAP Is Specifically Associated with NR2B
iWhat might be the molecular basis of the differential
rfunctions of NR2A and NR2B in AMPAR trafficking and
fsynaptic plasticity? An attractive hypothesis is that
eNR2A-NMDARs and NR2B-NMDARs are associated
lwith distinct signaling proteins. We therefore screened
ffor major PSD proteins that might coimmunoprecipitate
pselectively with NR2A or NR2B from rat brain extracts.
tTo obtain NR2A-enriched and NR2B-enriched NMDAR
Tcomplexes, we performed three sequential immuno-
nprecipitations with NR2A antibodies to clear the deoxy-
Echolate synaptosome extract of NR2A, followed by an
timmunoprecipitation with NR2B antibodies to purify re-
Smaining NR2B complexes from the NR2A-depleted su-
cpernatant (Figure 8A). The majority of NR2A protein was
tprecipitated in the first round of immunoprecipitation
with NR2A antibodies (Figure 8A, compare precipitate
S[row 1, lane 2] with supernatant after precipitation [row
b1, lane 3]). After the third round, NR2A was undetect-
Iable in the supernatant (lane 7). A minority of the total
dNR2B was precipitated with NR2A antibodies in the first
oround (row 2, lane 2); this coimmunoprecipitation is
sconsistent with the existence of a fraction of NMDARs
tcontaining both NR2A and NR2B (see also Sheng et al.,
s1994). Very small amounts of NR2B came down with
tthe subsequent two rounds of NR2A immunoprecipita-
ation. The remaining NR2B after NR2A “clearing,” how-
ever, was almost completely precipitated by the NR2B
santibody (Figure 8A, row 2, compare lane 8 and lane 9).
sAs expected, the NR1 subunit of NMDARs and
rthe NMDAR-associated scaffold protein PSD-95 were
sfound in both NR2A and NR2B immunoprecipitates. Re-
cmarkably, SynGAP was barely coimmunoprecipitated
Twith NR2A (Figure 8A, row 4, lane 2), but it strongly
Gcoprecipitated with NR2B even though NR2A had al-
mready been quantitatively depleted (row 4, lane 8). This
Npreferential association with NR2B is particularly obvi-
sous if one “normalizes” the SynGAP signal with the NR1
Nsignal in the same lanes, which serves as a rough index
of the amount of NMDAR precipitated. These coimmu-
noprecipitation data indicate that SynGAP is preferen- D
tially associated with NR2B rather than NR2A in adult
brain. The specific association of NR2B and SynGAP D
ooffers a biochemical means for the functional coupling
of NR2B-NMDARs to an enzyme that acts to shorten O
Nthe duration of activated (GTP-bound) Ras. In addition
to SynGAP, αCaMKII was also preferentially coimmuno- f
Gprecipitated with NR2B (Figure 8A, bottom row).
A substantial fraction of SynGAP and PSD-95 re- i
dmained in the supernatant even after NR2B and NR2A
had been largely cleared from the extract (Figure 8A, (
Nlane 9). This may be due to the molar excess of PSD-
95 and SynGAP over NMDARs that exists in the PSD a
m(Peng et al., 2004; J. Peng and M.S., unpublished data).
A substantial amount of NR1 also persisted in the su- N
cpernatant after precipitation of NR2A and NR2B, which
is consistent with earlier evidence that neurons have a 1
tlarge excess of NR1 over NR2 subunits (Huh and Went-
hold, 1999). GynGAP Negatively Regulates NMDA Receptor-
ediated ERK Activation
o test whether SynGAP is functionally coupled to
MDA receptor regulation of the Ras-ERK pathway, we
sed RNAi to specifically suppress SynGAP expression
n neurons (Figures 8B and 8C and Figure S2B). In neu-
ons transfected with SynGAP-RNAi, ERK activation
ollowing NMDA stimulation became sustained (still el-
vated at 6 min) rather than transient (Figure 8C). These
oss-of-function data indicate that SynGAP is important
or ERK deactivation following NMDA stimulation. Im-
ortantly, SynGAP-RNAi had no effect on ERK activa-
ion in response to KCl depolarization (Figure 8C).
hese results indicate that SynGAP selectively and
egatively regulates NMDA receptor-mediated Ras-
RK activation. Taken together, the coimmunoprecipi-
ation, ifenprodil, and SynGAP-RNAi data imply that
ynGAP is activated by NMDAR stimulation (specifi-
ally by NR2B-containing receptors), which then leads
o the turning off of the Ras-ERK pathway.
ynGAP Reduces Surface GluR1 Expression
y Inhibiting GluR1 Insertion
f SynGAP is a critical link between NR2B-NMDARs and
ownregulation of Ras and loss of surface GluR1, then
ne would predict that excessive activity of SynGAP
hould inhibit surface expression of GluR1. Indeed, cul-
ured hippocampal neurons transfected with SynGAP
howed reduced surface levels of GluR1 (w33% less
han control) (Figure 9A). Surface GluR2 levels were un-
ffected by SynGAP overexpression (Figure 9B).
We tested the effect of SynGAP overexpression on
urface insertion of GluR1 in the thrombin cleavage as-
ay (Figure 9C). At 25 min after thrombin washout, the
ecovery of surface HA/T-GluR1 immunoreactivity was
trongly reduced (by 50%–60%) in SynGAP-transfected
ells compared to cells transfected with β-gal alone.
hese data suggest that SynGAP depletes surface
luR1 by inhibiting GluR1 insertion into the plasma
embrane. Overall, SynGAP overexpression mimicks
R2B gain-of-function and NR2A loss-of-function, con-
istent with the idea that SynGAP acts downstream of
R2B and in opposition to NR2A.
iscussion
ifferential Effects of NR2A and NR2B
n AMPAR Trafficking
ur study reveals differential actions of NR2A- versus
R2B-NMDARs in Ras-ERK signaling and AMPAR traf-
icking. In mature neurons, the surface expression of
luR1 is supported by NR2A-containing NMDARs, but
s inhibited by NR2B-NMDARs. Because the synaptic
elivery of GluR1 is believed to be a key event in LTP
Malinow and Malenka, 2002), the opposing actions of
R2A and NR2B on GluR1 trafficking provides an
ttractive explanation for why LTP is sensitive to phar-
acological blockade of NR2A-NMDARs but not
R2B-NMDARs (Liu et al., 2004). The impaired hippo-
ampal LTP in NR2A knockout mice (Sakimura et al.,
995; Ito et al., 1997) is also consistent with our finding
hat NR2A is critical for activity-dependent delivery of
luR1 to the surface.
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755Figure 8. SynGAP Associates Specifically with NR2B and Negatively Regulates NMDA Receptor-Mediated ERK Activation
(A) Coimmunoprecipitation of SynGAP and NR2B. DOC extract of rat brain crude synaptosome membranes was immunoprecipitated with
control (nonimmune) rabbit IgG (right 3 lanes) or affinity-purified NR2A antibody. Three sequential immunoprecipitations with NR2A-specific
antibody were performed until NR2A was quantitatively removed. The remaining supernatant after NR2A depletion was then precipitated with
NR2B-specific antibody. The inputs (I; lanes 1, 10), and immunoprecipitated pellets (P; lanes 2, 4, 6, 8, 11), and supernatant after immunopreci-
pitation (S; lanes 3, 5, 7, 9, 12) were immunoblotted for the indicated proteins at left. Arrowheads point to specific bands; the diffuse bands
in the P (pellet) lanes that run beneath the specific band are due to the IgGs used for immunoprecipitation.
(B) RNAi knockdown of endogenous SynGAP. Cultured hippocampal neurons at DIV14 were cotransfected with pSUPER or SynGAP-RNAi
plus β-gal (4:1 ratio). At DIV17, neurons were triple labeled for β-gal, SynGAP, and PSD-95 antibody.
(C) SynGAP-RNAi prolongs NMDA receptor-mediated ERK activation. Hippocampal neurons at DIV14 were cotransfected with pSUPER or
SynGAP-RNAi plus β-gal (4:1 ratio). At DIV17, neurons were pretreated with 1 M TTX, 40 M CNQX, and 5 M nimodipine for 1 hr, then
stimulated with 70 M NMDA (3 or 6 min). For KCl depolarization, neurons were treated with 55 mM KCl. ERK activation was assayed by
immunostaining with phospho-ERK antibody. Arrows point to soma of transfected neurons. For quantification of phospho-ERK intensity,
fluorescence intensity over cell soma was measured and normalized to ERK activation levels at 3 min in untransfected neurons (n = 16–17
for each histogram; **p < 0.01, compared with untransfected or pSUPER transfected neurons).An interesting finding is that surface levels of GluR1
and GluR2 are not coordinately regulated. Pharmaco-
logical and/or molecular manipulations of NR2A and
NR2B strongly affected surface GluR1, with little effect
on GluR2. In hippocampus, AMPARs are mainly com-
posed of GluR1/GluR2 or GluR2/GluR3 combinations,
with a small minority of GluR1 homomers (Wenthold et
al., 1996); the precise subunit stoichiometries of these
AMPARs are not known. Because NR2B overexpres-
sion reduces surface GluR1 selectively, we suppose
that the loss of surface GluR1/GluR2 is counterbal-
anced by a gain in GluR2/GluR3 receptors, such that
overall GluR2 levels on the surface are unchanged.
Specific Coupling of NR2B to SynGAP
The reduction of surface GluR1 by NR2B overexpres-
sion or NR2A knockdown and the increase of surfaceGluR1 by NR2B antagonists all argue that NR2B-
NMDARs in mature neurons actively inhibit GluR1 deliv-
ery to the cell surface. Consistent with this action, we
found that in mature neurons NR2B is coupled to the
inhibition rather than the activation of Ras-ERK, the sig-
naling pathway that drives GluR1 to synapses (Zhu et
al., 2002). An unexpected discovery was that the abun-
dant postsynaptic RasGAP SynGAP is mainly associ-
ated with an NR2B receptor complex that lacks NR2A.
Moreover, SynGAP overexpression mimicks NR2B gain-
of-function in terms of surface expression and insertion
of GluR1. Heterozygous SynGAP–/+ mutant mice show
elevated levels of phospho-ERK (Komiyama et al.,
2002) and increased synaptic staining of GluR1 (Kim et
al., 2003), confirming that SynGAP is also an inhibitor
of Ras-ERK and synaptic AMPAR trafficking in vivo.
An unanswered question is how SynGAP preferen-
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(A and B) Cultured hippocampal neurons at DIV14 were transfected with β-gal or HA-SynGAP, and 2 days later, surface GluR1 (A) and surface
GluR2 (B) were measured.
(C) Quantitation of data from (A) and (B). n = 25, 20, 24, 38, 25, and 31 from left to right; **p < 0.01, ***p < 0.001.
(D) Reduced surface delivery of HA/T-GluR1 in SynGAP-transfected neurons. Cultured hippocampal neurons at DIV14 were transfected with
HA/T-GluR1 plus β-gal or HA/T-GluR1 plus Myc-SynGAP. Three days later, new HA/T-GluR1 insertion to the cell surface was measured at 25
min using the thrombin cleavage assay.
(E) Quantitation of results from (D); n = 15 for each. **p < 0.01, compared with β-gal-transfected neurons.tially links to NR2B, since SynGAP binds to PSD-95 family p
aproteins through a C terminus-PDZ interaction (Chen et
al., 1998; Kim et al., 1998). One possibility is that Syn- a
pGAP binds specifically to a member of the PSD-95
family that is preferentially complexed with NR2B, such G
as SAP102 (Sans et al., 2000). In addition, C-terminal
splice variants of SynGAP have been described that N
Tlack the PDZ binding motif but which bind to αCaMKII
(Li et al., 2001). Because αCaMKII binds to the cyto- clasmic tail of NR2B (but not NR2A) in vitro (Leonard et
l., 1999; Strack et al., 2000), and is primarily associ-
ted with NR2B in brain extracts (this study), it could
lay a role in mediating the specific association of Syn-
AP with NR2B.
We show here that ifenprodil enhances and prolongs
MDA-induced Ras-ERK activation in mature neurons.
his effect could be mimicked by RNAi of SynGAP, indi-
ating that SynGAP is critical for termination of NMDA
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757receptor-mediated Ras-ERK activation. Together with
the specific association of SynGAP with NR2B, these
data imply that SynGAP is a major mediator of the in-
hibitory effects of NR2B-NMDARs on Ras-ERK signal-
ing and hence GluR1 surface expression. Recently Oh
et al., (2004) identified specific residues in SynGAP
whose phosphorylation by CaMKII leads to increased
RasGAP activity of SynGAP. Moreover, NMDAR activa-
tion induces phosphorylation of SynGAP on a subset of
these sites (Oh et al., 2004). Thus, there is considerable
evidence that NMDA receptor stimulation leads to the
activation of SynGAP. With CaMKII in the same protein
complex as SynGAP and NR2B, an attractive idea
is that Ca2+ influx through NR2B-NMDARs stimulates
the sequential activation of the associated enzymes
CaMKII and SynGAP, leading to inactivation of Ras. Be-
cause activated Ras drives GluR1 to synapses, such a
model can explain how NR2B and SynGAP inhibit sur-
face expression of GluR1.
Our finding that NR2B receptors are necessary and
sufficient for NMDA-induced internalization of AMPARs
can explain why activation of NR2B-NMDARs is essen-
tial for LTD (Liu et al., 2004). However, the molecular
mechanism by which the NR2B receptor signals to
cause LTD remains to be clarified. One possibility aris-
ing from our study is that deactivation of Ras by NR2B-
NMDARs is critical for LTD induction. Perhaps inhibition
of Ras is required to prevent the surface delivery/re-
cycling of internalized AMPARs, which is an important
factor in redistributing AMPARs from the surface to the
inside of the cell (Lee et al., 2004). Somewhat against
this idea is that overexpression of NR2B and SynGAP
inhibits the surface delivery of GluR1 rather than GluR2,
and it is generally thought that GluR2 is the more im-
portant subunit for determining internalization and LTD
(Zhu et al., 2002; Lee et al., 2004). Another possibility is
that NR2B-NMDARs are coupled to LTD signaling path-
ways that were not addressed in this study, such as
Rap or protein phosphatases.
NR2A, NR2B, and ERK Activation
Why is NR2A required for LTP? Our study demonstrates
that NR2A-NMDARs are sufficient to activate Ras-ERK,
and indeed they appear to sustain Ras-ERK activation
for a longer duration when NR2B-NMDARs are blocked.
Moreover, NR2A is involved in driving surface delivery
of GluR1. Thus, the simplest hypothesis is that NR2A-
NMDARs are the main mediators of NMDA-induced
Ras-ERK signaling and GluR1 delivery to synapses,
both of which are critical steps in NMDAR-dependent
LTP. The molecular mechanisms by which NR2A is cou-
pled to Ras activation are presently unknown.
Krapivinsky et al. (2003) reported that the RasGEF
RasGRF1 binds directly to the cytoplasmic tail of NR2B
but not NR2A, and that NMDA-induced ERK activation
was blocked by overexpression of a NR2B C-terminal
fragment that contains the RasGRF1 binding site.
Moreover, by measuring ifenprodil sensitivity of NMDA-
induced ERK activation in hippocampal neurons de-
veloping in culture, they suggested that ERK activation
depends primarily on NR2B-containing receptors, from
DIV8 to DIV30 (Krapivinsky et al., 2003). Our data ap-
pear to be at odds with these results. Based on molec-ular genetic evidence (RNAi combined with overexpres-
sion) (Figure 7), we find that in the absence/deficiency
of the other subtype, either NR2A- or NR2B-NMDARs
can support ERK activation. Moreover, in our hands,
NR2B antagonists caused prolongation and/or super-
activation of Ras-ERK in response to NMDA, particu-
larly in mature neurons. Overexpression of the large
NR2B C-terminal fragment used to disrupt the interac-
tion of NR2B and RasGRF1 (amino acids 886 to 1310,
which includes the CaMKII binding site of NR2B) may
cause unexpected effects (Krapivinsky et al., 2003). It
is more difficult to explain the discrepancy in the phar-
macological results, except to note that (1) we obtained
consistent results with two distinct NR2B-selective an-
tagonists, ifenprodil and Ro25-6981; (2) the NR2B-
mediated inhibition of ERK was most obvious in highly
mature neurons and at later times than the 3 min point
examined by Krapivinsky et al. (2003); (3) our quantita-
tive analysis was based on immunoblotting with phos-
pho-ERK antibodies, while Krapivinsky et al. used
immunostaining.
Based on our data, we suggest that either NR2A or
NR2B can induce ERK activation in response to NMDA
treatment. Specifically, we propose that NR2B plays a
major role in ERK activation in young neurons, where
NR2B is the major NR2 subunit. As neurons mature,
NR2A takes over the function of coupling to ERK acti-
vation, and in mature neurons, NR2B-NMDARs adopt
the role of shortening the duration of Ras/ERK acti-
vation.
Possible Cooperative Functions of NR2A and NR2B
In NR2 knockdown and “reconstitution” experiments
(Figure 4C), surface GluR1 was virtually undetectable
in neurons transfected with NR2B-RNAi and NR2A-
expression constructs, even though these cells showed
robust NMDA-induced ERK activation. The superficial
interpretation is that NR2A is necessary for normal sur-
face expression of GluR1, but is not sufficient to sup-
port surface GluR1 in the absence of NR2B. On the
other hand, NR2A-NMDARs alone are sufficient for me-
diating ERK activation. To explain the necessity but in-
sufficiency of NR2A, we hypothesize that triheteromeric
NMDARs containing both NR2A and NR2B (subunit
composition NR1/NR2A/NR2B) are needed to promote
the surface expression of GluR1. Such NR1/NR2A/
NR2B receptors are inferred to exist in the brain by
coimmunoprecipitation studies (Sheng et al., 1994; Luo
et al., 1997), and these triheteromeric receptors are not
highly sensitive to NR2B-selective antagonists like ifen-
prodil or Ro25-6981 (Fischer et al., 1997; Blevins et
al., 1997).
Because NR2A-mediated ERK signaling appears to
be insufficient for supporting surface GluR1 expres-
sion, the NR2B subunit may recruit additional signaling
molecules to the NR1/NR2A/NR2B receptor that are
essential for GluR1 surface delivery. In a more extreme
variation of this hypothesis, the NR2B subunits can
provide a specific “scaffolding” function in the PSD that
is required for the signaling of NR2A-NMDARs, without
even necessarily being in the same receptor-channel
complex as NR2A. In this model, NR2B-NMDARs bind
to a critical signaling mediator and recruit it to the
Neuron
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NNR2A-NMDARs. For such a scaffolding function, the
pNR2B-NMDARs need not be activated themselves
g
(thus insensitive to NR2B antagonists), but they need R
to be physically present close to NR2A-NMDARs (thus F
Tsensitive to RNAi knockdown).
lCaMKII is activated downstream of NMDARs and
pcritical for activity-dependent recruitment of GluR1 to
Csynapses. It also binds preferentially to the cytoplasmic
G
tail of NR2B rather than NR2A (Leonard et al., 1999; G
Strack et al., 2000), consistent with our coimmunopre- C
Ccipitation data. Thus, CaMKII would be a strong candi-
Tdate for the hypothetical signaling molecule whose
Apostsynaptic function depends on the scaffolding of
SNR2B subunits and the gating of NR2A-containing
A
NMDARs. If the recruitment of CaMKII to the PSD de- A
pends on NR2B subunits, it could explain why NR1/ G
GNR2A receptors by themselves are incapable of pro-
Tmoting surface GluR1 expression.
T
G
Effect of NR2B-RNAi on NR2A and NR1
NWhy did NR2B-RNAi lead to reduction of NR2A and
HNR1 in addition to loss of endogenous NR2B? It seems
1
unlikely that this effect is due to nonspecific knock- p
down of NR2A and NR1 by NR2B-RNAi, since NR2B- w
RNAi had no effect on NR2A or NR1 expression in het- p
1erologous cells. More likely the loss of NR2A is a
Csecondary consequence of NR2B knockdown in neu-
Frons. There is considerable evidence that NR2A expres-
m
sion is regulated by NMDAR activity (Bessho et al.,
1994; Quinlan et al., 1999; Hoffmann et al., 2000). For p
instance, APV inhibited the expression of NR2A but not f
fNR2B in cultured neurons (Hoffmann et al., 2000). Be-
Fcause NR2B is the predominant NR2 subunit in de-
Bveloping hippocampal neurons, a reasonable explana-
G
tion is that NR2B-RNAi caused a loss of NMDAR
activity that subsequently impaired NR2A expression. e
The reduction of NR1 staining in NR2B-RNAi-trans-
fected neurons can be explained easily as a secondary S
effect of the loss of NR2B and NR2A, since it is well- C
restablished that targeting and/or stability of multisub-
sunit membrane complexes depends on the integrity of
3all subunits. Indeed, NR2B-RNAi caused a selective
loss of NR1 staining in dendrites, and this could be res-
l
cued by NR2A coexpression. A reduction of postsynap- N
tic NR1 was also seen in cerebellar granule cells lacking P
bNR2A and NR2C (Abe et al., 2004), supporting the idea
that NR2 subunits are important for the synaptic
targeting of NMDARs. T
T
v
Experimental Procedures w
c
Antibodies 3
Antibodies used include mouse antibodies against PSD-95 (K28/ b
43, gift from J. Trimmer), HA (12CA5, Roche), αCaMKII (Sigma), t
GluR2 (MAB397, Chemicon); NR1 (54.1, PharMingen), Ras (Ras10, t
Upstate Biotechnology), Myc (9E10, Oncogene Science), NR2A l
(Zymed), NR2B (gift from A. Dunah), and β-galactosidase (Pro- v
mega), as well as rabbit antibodies against NR1, NR2B, NR2A i
(Sheng et al., 1994), phospho-ERK1/2 (Cell Signaling), ERK1/2 (Cell b
Signaling), HA (Y-11, Santa Cruz Biotechnology), β-galactosidase (
(ICN), GluR1 (Calbiochem), Myc (Cell Signaling), and SynGAP (Up- [
Nstate Biotechnology).NA Constructs
R2A and NR2B were expressed from pGW1-CMV. Expression
lasmids for HA-SynGAP and Myc-SynGAP came from Richard Hu-
anir, rat SAP102 expression vector from Craig Garner, and GST-
af-1RBD A85K mutant expression vector from A. Burgess, M.
ridman, and H. Maruta (Fridman et al., 2000). HA/T-GluR1 and HA/
-GluR2 were previously described (Passafaro et al., 2001). The fol-
owing oligonucleotides were inserted into the HindIII/BglII sites of
SUPER vector (Brummelkamp et al., 2002): NR2A-RNAi: 5#-GAT
CC CGG ATC CGA CAT CCA CGT TCT TCA AGA GAG AAC GTG
AT GTC GGA TCC TTT TTG GAA A3#; 5#AGC TTT TCC AAA AAG
AT CCG ACA TCC ACG TTC TCT CTT GAA GAA CGT GGA TGT
GG ATC CGG G-3#; NR2B-RNAi: 5#-GAT CCC CGG ATG AGT CCT
CA TGT TCT TCA AGA GAG AAC ATG GAG GAC TCA TCC TTT
TG GAA A-3#; 5#-AGC TTT TCC AAA AAG GAT GAG TCC TCC
TG TTC TCT CTT GAA GAA CAT GGA GGA CTC ATC CGG G-3#;
AP102-RNAi: 5#-GAT CCC CCA CCA ATC TGC AGG ATG TGT TCA
GA GAC ACA TCC TGC AGA TTG GTG TTT TT-3#; 5#-AGC TAA
AA CAC CAA TCT GCA GGA TGT GTC TCT TGA ACA CAT CCT
CA GAT TGG TGG GG-3#; SynGAP-RNAi: 5#-GAT CCC CGA AGC
AT ATT ACT GCG AGT TCA AGA GAC TCG CAG TAA TAT CGC
TC TTT TTG GAA A-3#; 5#-AGC TTT TCC AAA AAG AAG CGA TAT
AC TGC GAG TCT CTT GAA CTC GCA GTA ATA TCG CTT CGG
-3#.
euron Cultures, Transfection, and Immunostaining
ippocampal neuronal cultures were prepared from embryonic day
8–19 rats (Lee et al., 2002) and transfected with calcium phos-
hate. Cortical neurons were plated at a density of 3 × 105 cells/
ell in 12-well plates. For phospho-ERK staining, neurons were
retreated with 5 M nimodipine, 40 M CNQX, and 1 M TTX for
hr, and then stimulated with 70 M NMDA for 3 min and 6 min.
ells were fixed in 4% formaldehyde and 4% sucrose for 10 min.
or NR1, NR2A, and NR2B staining, neurons were fixed in 100%
ethanol at −20°C for 10 min.
Live staining of surface endogenous AMPARs was performed as
reviously described (Wyszynski et al., 2002). DIV30 neurons were
ixed under nonpermeabilizing conditions by incubation in 2%
ormaldehyde/4% sucrose/1× PBS for 4 min at room temperature.
ixed cells were incubated in ADB (4% normal goat serum, 0.1%
SA, 1× PBS) containing 10 µg/ml rabbit anti-GluR1 or mouse anti-
luR2 for 1 hr to decorate surface receptors.
AMPAR internalization assays and quantitation were performed
ssentially as in Lee et al. (2002) and Lee et al. (2004).
urface Biotinylation Assay
ortical neurons at DIV21 were used for surface biotinylation. Neu-
ons were pretreated with DMSO or 5 M ifenprodil for 10 min;
ubsequently, 70 M NMDA was added to the culture medium at
7°C. After 20 min, cell surface proteins were biotinylated with 600
g/ml Sulfo-NHS-SS-Biotin (Pierce) for 20 min at 4°C. Cells were
ysed with lysis buffer (20 mM sodium phosphate, pH 7.5, 150 mM
aCl, 0.1% SDS, 0.5% NP-40, 0.5% sodium deoxycholate, 1 mM
MSF). Biotinylated proteins were isolated with NeurtrAvidine
eads (Pierce).
hrombin Surface Cleavage Assay
hrombin surface cleavage assay was performed as described pre-
iously (Passafaro et al., 2001). For glycine stimulation, neurons
ere treated with glycine (200 M, 3 min) in extracellular solution
ontaining 150 mM NaCl, 2 mM CaCl2, 5 mM KCl, 10 mM HEPES,
0 mM glucose, 0.0005 mM TTX, 0.001 mM strychinine, 0.02 mM
icuculline methiodide (pH 7.4). Neurons were then incubated in
he same extracellular solution without glycine for 10 min at room
emperature to allow for new insertion of receptors. Neurons were
abeled with mouse anti-HA antibody (2 g/ml) for 1 hr at 4°C to
isualize the surface HA/T-GluR receptors and then fixed for 8 min
n 4% paraformaldehyde/4% sucrose. Neurons were then incu-
ated either with rabbit anti-HA (1 g/ml) or with rat HA-antibody
Roche) and rabbit Myc-antibody in GDB (30 mM phosphate buffer
pH 7.4] containing 0.1% gelatin, 0.3% Triton X-100, and 0.45 M
aCl) to label intracellular receptors.
Differential Functions of NR2A versus NR2B
759Ras Activation Assay
Cortical neurons at DIV21 were pretreated either with DMSO or 5
M ifenprodil for 20 min and then 70 M NMDA for indicated times.
For activation of extrasynaptic receptors, we used a synaptic
blockade approach with slight modification (Tovar and Westbrook,
2002). Neurons were treated with 20 M MK-801 for 30 min, during
which spontaneous synaptic glutamate release in culture was used
to block synaptic NMDA receptors. Neurons were then washed
with conditioned media and stimulated with 70 M NMDA for the
indicated times. Neurons were lysed in MLB buffer (25 mM HEPES
[pH 7.5], 150 mM NaCl, 1% NP-40, 10% glycerol, 10 mM MgCl2, 25
mM NaF, 1 mM EDTA, and 1 mM sodium orthovanadate). Lysates
were incubated with GST-Raf-1RBD A85K, precoupled to glutathi-
one-agarose-beads, at 4°C for 30 min.
Immunoprecipitation
Immuoprecipitation from sodium deoxycholate extracts of adult rat
cortex were as described (Wyszynski et al., 2002). Sequential im-
munoprecipitation with anti-NR2A antibody was performed for 2 hr
each round.
Image Acquisition and Quantification
Fluorescence images were acquired with a LSM510 confocal
microscope (Zeiss). All measurements were performed using Meta-
Morph software. For surface AMPAR quantification, dendrites from
transfected, and untransfected cells were carefully traced and sur-
face fluorescence intensity determined for the traced regions. For
quantification of phospho-ERK staining, intensity of fluorescence
of cell somas from transfected and untransfected cell were mea-
sured. Intensity was expressed in arbitrary units of fluorescence
per square area. Statistical analysis was performed with Student’s
t test.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/46/5/745/DC1/.
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